tiprankstipranks
Elan Corp. (JP:6099)
:6099

Elan Corp. (6099) AI Stock Analysis

Compare
1 Followers

Top Page

JP:6099

Elan Corp.

(6099)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
¥798.00
▲(9.47% Upside)
Action:ReiteratedDate:02/06/26
The score is driven primarily by strong financial quality (low leverage, consistent growth, solid returns) and supportive valuation (moderate P/E with a meaningful dividend). These positives are partially offset by mixed technical signals, with longer-term trend indicators still weak despite improving near-term momentum.
Positive Factors
Conservative balance sheet / low leverage
Very low debt-to-equity (~0.05 in 2025) and expanding equity provide durable financial flexibility. This reduces refinancing and solvency risk, supports capital allocation for dividends or reinvestment, and better insulates the company from cyclic stress over the next several quarters.
Negative Factors
Margin compression
Trend of declining operating and net margins versus earlier years suggests rising cost pressure or adverse mix. If structural, this can erode long-term earnings power and free cash flow margins, limiting the company's ability to expand margins even with steady revenues.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / low leverage
Very low debt-to-equity (~0.05 in 2025) and expanding equity provide durable financial flexibility. This reduces refinancing and solvency risk, supports capital allocation for dividends or reinvestment, and better insulates the company from cyclic stress over the next several quarters.
Read all positive factors

Elan Corp. (6099) vs. iShares MSCI Japan ETF (EWJ)

Elan Corp. Business Overview & Revenue Model

Company Description
Elan Corporation engages in the nursing and medical-care business. It provides services for rental with laundry service of clothes, towels, diapers, and other daily necessities to persons admitted to hospital patients and nursing home residents. T...

Elan Corp. Financial Statement Overview

Summary
Strong overall fundamentals supported by consistent revenue growth, healthy profitability, and a very conservative balance sheet with minimal leverage. Score is tempered by modest margin compression and some year-to-year volatility in cash conversion/free cash flow.
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
72
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue51.51B55.45B47.51B41.43B36.26B31.64B
Gross Profit11.11B11.87B10.72B9.75B9.03B7.88B
EBITDA4.87B5.59B4.49B3.85B3.53B2.92B
Net Income2.40B2.77B2.35B2.52B2.08B1.91B
Balance Sheet
Total Assets23.13B26.23B21.61B18.99B16.07B13.95B
Cash, Cash Equivalents and Short-Term Investments5.62B6.85B6.85B5.49B6.04B5.63B
Total Debt791.30M765.20M86.57M0.000.000.00
Total Liabilities10.08B11.55B9.10B8.18B7.08B6.46B
Stockholders Equity12.86B14.44B12.50B10.81B8.99B7.48B
Cash Flow
Free Cash Flow0.003.18B3.62B1.59B1.23B2.03B
Operating Cash Flow0.004.29B4.50B1.78B1.58B2.11B
Investing Cash Flow0.00-3.39B-2.23B-1.66B-624.51M-357.68M
Financing Cash Flow0.00-906.86M-849.53M-667.09M-552.96M-614.15M

Elan Corp. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price729.00
Price Trends
50DMA
714.76
Negative
100DMA
717.77
Negative
200DMA
757.42
Negative
Market Momentum
MACD
-1.36
Positive
RSI
40.65
Neutral
STOCH
19.82
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6099, the sentiment is Negative. The current price of 729 is below the 20-day moving average (MA) of 736.95, above the 50-day MA of 714.76, and below the 200-day MA of 757.42, indicating a bearish trend. The MACD of -1.36 indicates Positive momentum. The RSI at 40.65 is Neutral, neither overbought nor oversold. The STOCH value of 19.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6099.

Elan Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥2.98B27.022.56%-3.06%-38.56%
72
Outperform
¥43.41B14.6720.80%1.77%16.49%3.34%
72
Outperform
¥41.93B11.612.63%0.30%-31.28%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥5.72B23.204.07%6.08%38.00%
45
Neutral
¥6.14B33.861.41%18.03%-11.68%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6099
Elan Corp.
718.00
-19.78
-2.68%
JP:2373
Care Twentyone Corporation
426.00
30.91
7.82%
JP:2425
Care Service Co., Ltd.
783.00
-77.00
-8.95%
JP:6062
Charm Care Corporation
1,286.00
-26.41
-2.01%
JP:7061
Japan Hospice Holdings Inc.
733.00
-829.36
-53.08%

Elan Corp. Corporate Events

Elan Restores Prime Market Compliance by Lifting Tradable Share Ratio
Feb 4, 2026
ELAN reported that as of December 31, 2025 it now satisfies every TSE Prime Market continued listing requirement, largely by boosting its tradable share ratio above the 35% threshold through reclassifying shares once held by former CEO Hideharu Sa...
Elan Lifts Year-End Dividend to ¥15 Per Share
Feb 4, 2026
Elan’s board approved a year-end dividend of ¥15 per share for the fiscal year ended December 31, 2025, matching prior guidance and raising the total payout to ¥908 million, up from ¥787 million for the previous year. The deci...
Elan Posts Double-Digit Growth and Raises Dividend on Expanded Patient Services
Feb 4, 2026
Elan’s 2025 consolidated revenue rose 16.7% to ¥55.4 billion and operating profit climbed 19.5% to ¥4.27 billion, underpinned by higher patient-support service adoption, while net income grew 17.5% to ¥2.77 b...
Elan Corporation Announces Leadership and Departmental Restructuring
Dec 18, 2025
Elan Corporation has announced a series of executive and departmental personnel changes effective January 1, 2026, aimed at streamlining its operations and reinforcing its leadership structure. The realignment includes changes in responsibilities ...
Elan Corp. Reports Strong Financial Growth and Expansion
Nov 7, 2025
Elan Corp. reported a notable increase in its financial performance for the nine months ended September 30, 2025, with net sales rising by 16.9% and net profit attributable to owners increasing by 10.4% compared to the previous year. The company a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 06, 2026